
Sign up to save your podcasts
Or


What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
By Buck Joffrey5
3939 ratings
What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/

2,499 Listeners

3,861 Listeners

570 Listeners

7,208 Listeners

1,541 Listeners

403 Listeners

421 Listeners

8,544 Listeners

1,721 Listeners

9,249 Listeners

8,033 Listeners

715 Listeners

1,027 Listeners

29,247 Listeners

240 Listeners